Alfuzosin
Sold as Xatral xl, Alfuwin xl, Osfuzal xr, Rantral mr
N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide
Drag to rotate. Structure from PubChem CID 2092.
Background
Registration
- Applicants
- 3
- Registrations
- 4
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Sanofi-aventis South Africa (Pty) Ltd1 of 2 cancelled | Xatral xl, Alfuwin xl | 10mg, 10 mg | 350074, 410740 | S4 | PIPIL |
| Aurogen South Africa (Pty) LtdCancelled | Osfuzal xr | Not stated | 510717 | S4 | None |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Rantral mr | 10 mg | A400392 | S4 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Xatral xl 10 MG EACH TABLET CONTAINS ALFUZOSIN 10,0 mg | 10mgProlonged release tablets. | 35007435/5.2/0074Approved 20 February 2023 | Cancelled | S4 | PIPIL |
| Alfuwin xl EACH TABLET CONTAINS ALFUZOSIN HYDROCHLORIDE 10,0 mg | 10 mgProlonged release tablets | 41074041/5.2/0740Approved 4 February 2022 | Registered | S4 | PIPIL |
| Osfuzal xr EACH TABLET CONTAINS: ALFUZOSIN HYDROCHLORIDE 10,0 mg | Not listed | 51071751/5.2/0717 | Cancelled | S4 | None |
| Rantral mr 10 EACH TABLET CONTAINS: ALFUZOSIN 10,0 mg | 10 mgTablets | A400392A40/5.2/0392Approved 27 October 2022 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Alfuzosin
S4: Alfuzosin
Consolidated Schedules 06 July 2026, line 5182
Pharmacological class: Adrenolytics (sympatholytics). (class 5.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Xatral xl 10 MG, Sanofi-aventis South Africa (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.